The Study Success Blueprint
The Study Success Blueprint
Podcast Description
Share knowledge and strategies for successful clinical trials. The podcast will focus on launching new studies, making informed decisions, and sharing insights from, Physican researchers, industry professionals, academics, and commentators.
Podcast Insights
Content Themes
The podcast covers various topics including innovative clinical trial methodologies, the role of digital health, and strategies for engaging patients. Specific episodes feature discussions on extending patient care, the essence of collaboration in research, and financial stewardship in clinical trials, as demonstrated by guests like Dr. Andrew Sauer.

Share knowledge and strategies for successful clinical trials. The podcast will focus on launching new studies, making informed decisions, and sharing insights from, Physican researchers, industry professionals, academics, and commentators.
In the latest episode of the Study Success Blueprint podcast, host Matthew Mace interviews Catherine Gregor of Florence Health, diving deep into the ever-evolving world of clinical trial technology. They discuss the exciting potential of AI, the critical need for interoperability, and the importance of designing tech solutions with the end user in mind. Katherine highlights how the pandemic accelerated the adoption of innovative solutions like telehealth and emphasises the role of collaboration between tech vendors and healthcare providers to enhance efficiencies in clinical trials.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.